Friday 6 November 2026 Export VRDN’s income statement to Excel — free account

Viridian Therapeutics, Inc.

Viridian Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $70.8 million, up 23,359.9% from fiscal 2024.

Revenue: −63.5%
EPS: −5.00%
Free cash flow: −9.92%
Total debt: +1,064.9%

Quarter to September 2026, against a year earlier

Insider buying

28.50 0.05 −0.18%

Follow VRDN

Alert me

Market cap: $3.2B
P/E: 0.0×
Fwd P/E: −6.2×
Dividend yield: —
F-score: 3/9
Altman Z: 6.69
Beneish M: n/a
Dividend safety: n/a

Overview

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26 From the 10-Q filed 4 Nov
ROE Full definition →	+8 more TTM periods Free account	(63.87%)	(78.43%)	(86.93%)	0.00%
Piotroski F-Score Full definition →		3	2	4	—
ROA Full definition →		(41.73%)	(49.74%)	(46.08%)	(56.49%)
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		(41.54%)	(49.12%)	(37.93%)	(47.95%)
Average Days of Receivables Full definition →		0.00	0.00	384.87	0.00
Free Cash Flow per Share Full definition →		(3.26)	(2.97)	(3.11)	0.00
Free Cash Flow Full definition →		(276.89)	(303.82)	(335.04)	(343.44)
Capital Expenditures Full definition →		(0.49)	(0.43)	(1.70)	(1.94)
Other line items
Cash ROIC Full definition →		(16.81%)	(20.97%)	(17.77%)	(22.36%)
Accounts Receivable Turnover Full definition →		0.00	0.00	1.89	0.00
Accounts Payable Turnover Full definition →		0.00	0.00	0.00	0.00
Average Days of Payables Full definition →		0.00	0.00	0.00	0.00
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		478.38%	479.04%	456.47%	1,172.63%
Selling, General and Administrative Expense of Revenue Full definition →		134.53%	164.83%	213.21%	0.00%
Share Based Compensation of Revenue Full definition →		62.53%	66.94%	75.38%	226.52%
Interest Coverage Full definition →		(73.44)	(49.07)	(25.89)	—
Operating CF/Net income Full definition →		0.81	0.84	0.86	0.75
Depreciation/Fixed assets Full definition →		(5.13)	(5.16)	(2.07)	(1.99)
Capex/Depreciation Full definition →		0.08	0.07	0.30	0.33
Revenue per Share Full definition →		0.84	0.69	0.66	0.00
Operating CF per Share Full definition →		(3.26)	(2.97)	(3.09)	0.00
Capex per Share Full definition →		(0.01)	0.00	(0.02)	0.00
Capex to Sales Full definition →		0.01	0.01	0.02	0.07

Show all line items

Columns are period end dates · fundamentals updated 4 Nov 2026

Stockrow Weekly